KV-B: Headlines for K V PHARMA CL B - Yahoo! Canada Finance

Fri, Nov 13, 2009
•	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments PR Newswire (Fri, Nov 13)
Mon, Sep 21, 2009
•	KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) PR Newswire (Mon, Sep 21)
Tue, Sep 15, 2009
•	KV Pharmaceutical Receives Stockholder Action by Written Consent PR Newswire (Tue, Sep 15)
Wed, Sep 9, 2009
•	KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent PR Newswire (Wed, Sep 9)
Fri, Sep 4, 2009
•	KV Pharmaceutical Appoints Interim Chief Financial Officer PR Newswire (Fri, Sep 4)
Wed, Mar 4, 2009
•	Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B GlobeNewswire (Wed, Mar 4)
•	Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B GlobeNewswire (Wed, Mar 4)
Thu, Jan 22, 2009
•	Brower Piven Announces Expanded Class Period and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in KV Pharmaceutical Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit B Marketwire (Thu, Jan 22)
Wed, Jan 14, 2009
•	Milberg LLP Announces Its Investigation on Behalf of Certain Investors of KV Pharmaceutical -- KV.A Marketwire (Wed, Jan 14)
Fri, Dec 5, 2008
•	Dyer & Berens LLP Files Class Action Lawsuit On Behalf of Certain KV Pharmaceutical Company Investors -- KV-A, KV-B, KVPHP GlobeNewswire (Fri, Dec 5)
Wed, Dec 3, 2008
•	Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in KV Pharmaceutical Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the February 2, 2009 Lead Plai Marketwire (Wed, Dec 3)
Older Headlines
View headlines from:

Add to Portfolio

Email to a Friend

•